ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,702Medicare Part D Prescriptions Filled, Including Refills

Rank: 267 out of 939

$508K Total Retail Price of All Prescriptions

Rank: 235 out of 939

377 Patients Receiving at Least One Drug in Part D
44%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

29% of this provider’s 377 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

31% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 3,533 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 678 196 S3 1 1
FENTANYL 329 103 S2 2 104
CARISOPRODOL 294 0 R 3 51
OMEPRAZOLE 245 87 4 5
ZOLPIDEM TARTRATE 225 47 5 20
AMLODIPINE BESYLATE 225 101 5 6
ATENOLOL 223 90 7 19
LISINOPRIL 219 96 8 3
FUROSEMIDE 212 121 9 7
PROAIR HFA 210 59 10 41
OXYCODONE HCL 207 42 S2 11 67
LEVOTHYROXINE SODIUM 191 114 12 4
CEPHALEXIN 189 54 13 77
OXYCODONE HCL-ACETAMINOPHEN 185 25 S2 14 107
METFORMIN HCL 170 90 15 8
POTASSIUM CHLORIDE 170 101 15 9
HYDROCHLOROTHIAZIDE 169 73 17 12
FLUTICASONE PROPIONATE 167 66 18 43
ENDOCET 148 47 S2 19 148
LYRICA 145 48 20 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 139 80 21 23
ROPINIROLE HCL 122 43 22 78
GABAPENTIN 118 40 23 11
OXYCODONE-ACETAMINOPHEN 116 28 S2 24 138
NEXIUM 114 20 25 18
WARFARIN SODIUM 110 67 26 17
VENTOLIN HFA 107 33 27 80
METHADONE HCL 102 11 S2 28 109
SIMVASTATIN 101 60 29 2
TRAMADOL HCL 98 27 30 16
CITALOPRAM HBR 94 19 31 15
PREDNISONE 89 32 32 42
AZITHROMYCIN 88 40 33 32
CYMBALTA 79 46 34 44
METOPROLOL TARTRATE 74 34 35 10
SINGULAIR 73 15 36 101
ESTRADIOL 72 19 R 37 79
CARVEDILOL 72 37 37 25
PRAVASTATIN SODIUM 65 47 39 13
ADVAIR DISKUS 62 34 40 60
CYCLOBENZAPRINE HCL 62 13 R 40 36
ATORVASTATIN CALCIUM 61 27 42 22
PROMETHAZINE HCL 60 0 R 43 68
NAPROXEN 60 40 43 72
SERTRALINE HCL 56 25 45 24
CARBIDOPA-LEVODOPA 54 41 46 102
PAROXETINE HCL 54 21 46 70
DONEPEZIL HCL 53 33 48 30
QUETIAPINE FUMARATE 52 0 49 69
LOVASTATIN 51 29 50 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.